Zenicor Medical Systems

What Zenicor Medical Systems does

Zenicor Medical Systems AB is a Swedish medical technology company founded in 2003, headquartered in Stockholm, that specializes in early diagnosis of cardiac arrhythmias, particularly atrial fibrillation, and stroke prevention. The company sells its solutions primarily to public healthcare providers, hospitals, cardiology clinics, stroke units, and primary care centers across ten European countries (Sweden, Finland, the United Kingdom, Germany, Switzerland, and others), with selected research use cases in Australia via the SAFER-AUS study. Its core offering is the Zenicor Solution, an integrated platform combining the Zenicor One handheld thumb-ECG device (with 4G/5G data transmission), the Zenicor Flex continuous ECG monitor (patch or electrodes), the Zenicor View web-based management platform, and the Zenicor Direct outsourced ECG interpretation service. The system holds ISO 13485 certification and European MDR certification as of January 2023.

Name

Zenicor Medical Systems

Legal name

Zenicor Medical Systems AB

Website

https://zenicor.se

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Zenicor Medical Systems is a Swedish medical technology company that develops and sells integrated ECG-based diagnostic solutions for early arrhythmia detection and stroke prevention to public and private healthcare providers across ten European countries.

Ownership category

akta.pro rank

Product category

Cardiac Diagnostics Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Cardiology Telemedicine Platforms (HLALAGAB)

Keywords

• Cardiac arrhythmia diagnostics
• ECG monitoring devices
• Atrial fibrillation screening
• Stroke prevention platform
• Medical telemetry hardware

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Hardware sales (EKG devices): Sale of Zenicor One and Zenicor Flex ECG hardware to healthcare providers. Revenue recognized over time as devices are deployed.
2. Software/Platform subscription: Zenicor View platform subscription for managing ECG data. Some revenues follow a business model where payment is received per completed patient examination.
3. Interpretation services (Zenicor Direct): Customized ECG interpretation services sold to healthcare providers. Revenue recognized as services are delivered.
4. Research projects and grants: Revenue from research collaborations including SAFER, STROKESTOP studies and EU Horizon 2020 projects. Vinnova funding of 500,000 SEK received.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Zenicor Medical Systems develops and sells ECG-based medical devices and a connected software platform for early diagnosis of cardiac arrhythmias, primarily atrial fibrillation, and stroke prevention. Its portfolio includes the Zenicor One thumb-ECG device, the Zenicor Flex continuous ECG patch/electrode solution, the Zenicor View web-based management platform, the Zenicor Direct ECG interpretation service, and the DeepRhythmAI diagnostic AI. Products are sold to hospitals, stroke clinics, cardiology clinics, and primary care centers across Europe.

Product overview

Zenicor Medical Systems offers a unified platform-plus-modules architecture called Zenicor Solution for early arrhythmia diagnosis and stroke prevention. The core platform is Zenicor View, a web-based system that manages all arrhythmia investigation types. Two hardware modules — Zenicor One (a handheld thumb-ECG for intermittent monitoring) and Zenicor Flex (a patch or electrode-based continuous ECG device) — feed data into Zenicor View, enabling healthcare providers to select the most appropriate method per patient. The service layer Zenicor Direct provides outsourced ECG interpretation and device logistics for providers lacking in-house cardiac expertise. Advanced AI capability is delivered through DeepRhythmAI (from Medicalgorithmics), which is integrated into Zenicor Solution to automate arrhythmia detection in ECG data.

Differentiator

Problem solved

Functional benefit

Brands

• Zenicor One: Long-term arrhythmia assessment solution - thumb-ECG with simple transfer via 4G/5G
• Zenicor Flex
• Zenicor View
• Zenicor Direct
• DeepRhythmAI

Products and services

• Zenicor One A handheld thumb-ECG device that enables patients to record short ECG episodes that are automatically transmitted via 4G/5G mobile networks to a central database for physician review. Optimized for long-term intermittent arrhythmia assessment, it is used in screening studies including STROKESTOP I/II/III and SAFER.
• Zenicor Flex A flexible continuous ECG monitoring solution using either a patch or standard electrodes, designed for continuous arrhythmia assessment and managed within the same Zenicor View platform as Zenicor One.
• Zenicor View

Quantifiable outcome

• Stroke due to atrial fibrillation can be prevented in 70% of cases if detected early and treated with anticoagulants
• +3 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• MedicalgorithmicscoreTechnology or Integration · 1 January 2023AI company partnership to integrate DeepRhythmAI advanced artificial intelligence into the Zenicor Solution platform for enhanced arrhythmia diagnostics.
• Oulu Sydänkeskus (Oulu Heart Center)coreStrategic or Co-development Partner · 1 January 2018Finland's largest private cardiology center providing ECG interpretation for Zenicor-EKG. Extended services to all primary care centers in northern Finland. Also involved Biosense Webster (Johnson & Johnson) as partner.
• Tampere Heart HospitalcoreChannel Partner/ Reseller/ Distributor · 1 January 2018Second major primary care agreement in Finland. Partnership enables Zenicor-EKG to reach over half of Finland's primary care centers alongside Oulu Heart Center.
• University of Cambridge / NIHRcoreStrategic or Co-development Partner · 1 January 2018SAFER study led by Prof. Jonathan Mant at University of Cambridge, financed by NIHR (National Institute for Health Research). World's largest atrial fibrillation screening project with 300 NHS primary care units and 120,000 participants over 3 years.
• BNK (Bundesverband Niedergelassener Kardiologen) Service GmbHcoreChannel Partner/ Reseller/ Distributor · 5 July 2017Partnership with German cardiology association covering 900 member cardiology practices. Conducting screening projects in Germany with Pfizer. Ram agreement signed April 2016 and renewed January 2017.
• PfizercoreStrategic or Co-development Partner · 5 July 2017Partnership with pharmaceutical company Pfizer on screening projects for atrial fibrillation in Germany. Collaboration started in 2011 in Scandinavia and extended to Germany in 2017.
• Technomed Ltd.coreChannel Partner/ Reseller/ Distributor · 11 May 2017Exclusive partner for sales and marketing of Zenicor products and services in UK and Ireland. Also offers complete product and service offering with ECG interpretation via their ECG OnDemand service.
• Karolinska InstitutetcoreStrategic or Co-development Partner · 1 January 2017Research collaboration on atrial fibrillation and screening. STROKESTOP I and II studies conducted with Karolinska Institutet. AI collaboration project ongoing.
• Biosense Webster (Johnson & Johnson)minorStrategic or Co-development Partner · 1 January 2017Partner in Finnish care pathway optimization project alongside Oulu Heart Center.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• AliveCor: AliveCor (KardiaMobile) makes handheld/personal ECG devices with AI-based AF detection for both consumer and clinical use. It is the most direct competitor to Zenicor One in the AF-screening workflow.
• iRhythm Technologies: iRhythm's Zio patch is a continuous ambulatory ECG monitoring service for arrhythmia detection. It directly competes with Zenicor Flex and the Zenicor View platform in the clinical cardiac monitoring category.
• Preventice Solutions (Boston Scientific): Preventice (acquired by Boston Scientific) offers the BodyGuardian remote cardiac monitoring platform with patch-based continuous ECG. Closely comparable to Zenicor Flex's patch-ECG offering and cloud-based review workflow.

Broad incumbents

• Philips (BioTelemetry): Philips acquired BioTelemetry, one of the largest remote cardiac monitoring companies (e.g., MCOT). It is a broad incumbent competing across hospital ECG, ambulatory monitoring, and AI-driven arrhythmia diagnostics.
• GE HealthCare: GE HealthCare (MUSE ECG systems, patient monitoring portfolio) competes broadly in hospital cardiac diagnostics and monitoring. As a large incumbent, it offers overlapping ECG and arrhythmia-monitoring capabilities as part of a much wider portfolio.

Regional players

• Schiller AG: Schiller (Switzerland) is a European manufacturer of ECG devices, Holter monitors, and cardiopulmonary diagnostics with strong presence in German-speaking markets — a regional incumbent comparable to Zenicor in product category.
• Cardioline: Cardioline (Italy) is a European manufacturer of resting ECG, Holter, and stress-test systems. It is comparable as a regional ECG/arrhythmia-diagnostics player with overlapping European hospital and primary-care customers.

Emerging players

• Biotricity: Biotricity provides remote cardiac monitoring solutions (e.g., Bioflux) with continuous ECG and AI-driven arrhythmia detection. Comparable as an emerging player in remote cardiac diagnostics focused on chronic-condition monitoring.
• CardioSignal: CardioSignal (Finland) develops smartphone-based AF detection using motion-sensor and ECG signals. Comparable as an emerging AF-detection technology player intersecting with Zenicor's AF-screening market.

Others

• Medicalgorithmics: Medicalgorithmics develops the DeepRhythmAI arrhythmia-detection AI that is integrated into the Zenicor platform. Listed as an enabling technology partner rather than a competitor, but adjacent in the cardiac-diagnostics value chain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zenicor-medical-systems-ab

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zenicor Medical Systems